Immatics USA News and Activities

Immatics USA is owned by Immatics.

Immatics is a company listed under the stock ticker IMTX (DE).

Immatics has a direct presence in 2 countries.

View the org chart displaying its 11 main executives

Most searched biographies at Immatics USA

• Delfi Krishna, Vice President, Late-Stage Development
• Tymissha Jackson, Head of Regulatory Affairs
• Arun Satelli, Senior Director, Precision Medicine & Biomarkers

Popular executive movements at Immatics USA

• Viet Nguyen, Vice President, Operations, has left the company  (posted on April 15 2026).

Popular executive movements at Immatics

• Andy Deig has joined the company as Senior Vice President, Finance  (posted on April 16 2026).
• Amie Krause has joined the company as Chief People Officer  (posted on October 28 2025).
• Venkat Ramanan has joined the company as Chief Financial Officer  (posted on October 1 2025).

Create your alert
to follow the executive moves at Immatics USA.

Immatics has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Immatics USA

Social media about Immatics USA

• Immatics USA on Wikipedia, Google News & Yahoo Finance
• Immatics USA on LinkedIn, X (Twitter) & YouTube